https://www.selleckchem.com/pr....oducts/jak-inhibitor
Objective To investigate the possible mechanism of doxorubicin hydrochloride (DOX) inhibiting the proliferation of HT29 and HCT15 colon cancer cells. Methods The gradient concentrations of (0, 0.08, 0.16, 0.32, 0.64, 1.28) μmol/L DOX were used to treat HT29 and HCT15 cells for 24, 48 and 72 hours, and the cell proliferation activity was detected by CCK-8 assay to determine the optimal DOX concentration and treatment time. According to different treatments, HT29 and HCT15 cells were divided into 2 groups control group (only DMSO
Like
Comment
Share
